<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37482382</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1319-6138</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Neurosciences (Riyadh, Saudi Arabia)</Title><ISOAbbreviation>Neurosciences (Riyadh)</ISOAbbreviation></Journal><ArticleTitle>An evaluation of neuropsychiatric manifestations in systemic lupus erythematosus patients in Saudi Arabia and their associated factors.</ArticleTitle><Pagination><StartPage>177</StartPage><EndPage>183</EndPage><MedlinePgn>177-183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.17712/nsj.2023.3.20220127</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To establish the prevalence of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) symptoms in Saudi Arabia and the variables that are linked to it.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional study was conducted in June 2021 among SLE patients in Saudi Arabia. The Saudi Rheumatism Association exploited social media platforms to provide a self-administered online questionnaire to SLE patients. All data analyses were performed using the Statistical Packages for Social Sciences (SPSS) version 26.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred and eight SLE patients participated in the study (females 91.3% vs. males 8.7%). In addition, 13.5% of patients had a family history of SLE, and 26% had SLE for one to 3 years. The most common symptoms of NPSLE were alteration or loss of sensation (53.4%), followed by fear (52.4%), and headache (48.1%). The prevalence of patients with NPSLE was 40%. In a multivariate regression model, fear, altered sensations, cerebrovascular illness, sleep disruption, and diminished interest in routine activities were identified as independent risk variables for NPSLE CONCLUSION: Nearly half of SLE patients demonstrated NP manifestations, with significant symptoms including fear, alteration of sensation, cerebrovascular disease, sleep disturbance, and reduced interest in normal activities. To detect the pathophysiology of NPSLE, it is necessary to understand the relationship between neuropsychiatric morbidity and other relevant rheumatic disorders in the SLE population.</AbstractText><CopyrightInformation>Copyright: &#xa9; Neurosciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alammari</LastName><ForeName>Yousef M</ForeName><Initials>YM</Initials><Identifier Source="ORCID">0000-0002-5318-4689</Identifier><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaddoury</LastName><ForeName>Mahmoud A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alaryni</LastName><ForeName>Abdullah A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Abdullah H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>Sara A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almohaini</LastName><ForeName>Reem A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaleem</LastName><ForeName>Lena S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allowaihiq</LastName><ForeName>Lujain H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrashid</LastName><ForeName>Maha H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine (Alammari, Alaryni, Alghamdi, Alharbi, Almohaini, Alsaleem, Allowaihiq, Alrashid), College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, and from Department of Community Medicine (Gaddoury), Faculty of Medicine, King Abdulaziz University (KAU), Jeddah, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>Neurosciences (Riyadh)</MedlineTA><NlmUniqueID>101252453</NlmUniqueID><ISSNLinking>1319-6138</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020945" MajorTopicYN="Y">Lupus Vasculitis, Central Nervous System</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>23</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37482382</ArticleId><ArticleId IdType="pmc">PMC10519659</ArticleId><ArticleId IdType="doi">10.17712/nsj.2023.3.20220127</ArticleId><ArticleId IdType="pii">28/3/177</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D&#x2019;Cruz DP, Khamashta MA, Hughes GR.. Systemic lupus erythematosus. Lancet 2007; 369: 587&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">17307106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall&#x2019;Era M. Systemic lupus erythematosus. In: Imboden JB, Hellman DB, Stone JH, editor. Current Rheumatology Diagnosis and Treatment. 3rd ed. New York (NY): McGraw-Hill; 2013.</Citation></Reference><Reference><Citation>Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Mousa MM, et al. . Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 2002; 23: 87&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">11938371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujieda Y. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus. Immunol Med 2020; 43: 135&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">32459601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulinello M, Wen J, Putterman C.. Neuropsychiatric Symptoms in Lupus. Psychiatr Ann 2012; 42: 322&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302271</ArticleId><ArticleId IdType="pubmed">25620816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A.. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">11502919</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MI, Qureshi H, Akhtar S, Bae SJ, Hassan F.. Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and meta-analysis. Front Psychiatry 2023; 14: 1098734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931908</ArticleId><ArticleId IdType="pubmed">36816415</ArticleId></ArticleIdList></Reference><Reference><Citation>The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">10211873</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu A, Kao AH.. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol 2011; 9:449&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3151599</ArticleId><ArticleId IdType="pubmed">22379459</ArticleId></ArticleIdList></Reference><Reference><Citation>Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. . Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58: 1214&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">11971089</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. . Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol 2019; 71: 281&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6353684</ArticleId><ArticleId IdType="pubmed">30375754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu TY, Tam LS, Lee VW, Lee KK, Li EK.. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong. Rheumatology (Oxford) 2009; 48: 564&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pubmed">19269959</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscal E, Brey RL.. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin 2010; 28: 61&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2981505</ArticleId><ArticleId IdType="pubmed">19932376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, et al. . The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice. Lupus 2011; 20: 485&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">21339241</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, et al. . Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Seminars in Arthritis and Rheumatism 2012; 42: 179&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">22595642</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissa M, Medhat BM, Moghazy A.. AB0606 Neuropsychiatric lupus in a sample of Egyptian patients with systemic lupus erythematosus: prevalence and clinical characteristics. Annals of the Rheumatic Diseases 2018; 77: 1454.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez H, Cevallos A, Jimbo Sotomayor R, Naranjo-Saltos F, Mera Orces D, Basantes E.. Mental disorders in systemic lupus erythematosus: a cohort study. Rheumatol Int 2019; 39: 1689&#x2013;1695.</Citation><ArticleIdList><ArticleId IdType="pubmed">31432225</ArticleId></ArticleIdList></Reference><Reference><Citation>Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G.. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011; 41: 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965549</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>